Probiotic mixture VSL#3:An overview of basic and clinical studies in chronic diseases

被引:1
|
作者
Fang-Shu Cheng [1 ,2 ]
Dan Pan [3 ]
Bing Chang [4 ]
Min Jiang [4 ]
Li-Xuan Sang [3 ]
机构
[1] Department of Dermatology,Shengjing Hospital of China Medical University
[2] China Medical University
[3] Department of Geriatrics,the First Affiliated Hospital,China Medical University
[4] Department of Gastroenterology,the First Affiliated Hospital,China Medical University
关键词
VSL#3; Intestinal barrier function; Chronic diseases; Intestinal microbial balance; Cytokines; Therapeutic use;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Probiotics are known as "live microorganisms" and have been proven to have a health effect on hosts at the proper dose. Recently, a kind of probiotic mixture including eight live bacterial strains, VSL#3, has attracted considerable attention for its combined effect. VSL#3 is the only probiotic considered as a kind of medical food; it mainly participates in the regulation of the intestinal barrier function, including improving tight junction protein function, balancing intestinal microbial composition, regulating immune-related cytokine expression and so on. The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans (including children). We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies,including digestive systemic diseases (gastrointestinal diseases and hepatic diseases), obesity and diabetes, allergic diseases, nervous systemic diseases,atherosclerosis, bone diseases, and female reproductive systemic diseases.
引用
收藏
页码:1361 / 1384
页数:24
相关论文
共 50 条
  • [41] Molecular insights into the impact of antibiotic and VSL#3® probiotic therapy on the microbiota of patients with pouchitis
    Gonsalves, S.
    Lim, M.
    Wilcox, M.
    Sagar, P.
    Burke, D.
    Finan, P.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 28 - 29
  • [42] The probiotic mix, VSL#3, blocks a bacterial superantigen-driven murine enteropathy
    Lu, J
    De Simone, C
    McKay, D
    FASEB JOURNAL, 2005, 19 (04): : A496 - A496
  • [43] Effect of a Probiotic Preparation (VSL#3) in the Patients With Ulcerative Colitis: Its Effect on Cytokine
    Lee, Ji Hyun
    Moon, Gyoo
    Kwon, Hyeok Jin
    Jung, Woo Jin
    Seo, Pyoung Ju
    Lee, Ju Hyeong
    Kim, Hyun Shig
    GASTROENTEROLOGY, 2012, 142 (05) : S385 - S385
  • [44] Effect of the Probiotic VSL#3 on the Transition From Chronic Inflammation to Dysplasia in a Model of Colitis-Associated Colon Cancer
    Appleyard, Caroline B.
    Passalacqua, Idamary
    Isidro, Angel A.
    Cruz, Myrella L.
    Isidro, Raymond A.
    Rapale, Victor A. Rodriguez
    De Simone, Claudio
    GASTROENTEROLOGY, 2010, 138 (05) : S67 - S67
  • [45] Probiotic Mixture VSL#3 Alleviates Dextran Sulfate Sodium-induced Colitis in Mice by Downregulating T Follicular Helper Cells
    Xiao-jing Liu
    Ran Yu
    Kai-fang Zou
    Current Medical Science, 2019, 39 : 371 - 378
  • [46] Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis
    Mennigen, Rudolf
    Nolte, Kerstin
    Rijcken, Emile
    Utech, Markus
    Loeffler, Bettina
    Senninger, Norbert
    Bruewer, Matthias
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (05): : G1140 - G1149
  • [47] Probiotic mixture VSL#3 prevents ulcerative colitis-associated carcinogenesis in mice and cells by regulating the inflammatory and Wnt/β-catenin pathway
    Li, Wenbin
    Wang, Yanan
    Wang, Chunsaier
    Wang, Hongying
    Ma, Yiming
    Yang, Hong
    Zhao, Xinhua
    Hu, Xiaomin
    Kao, John Y.
    Qian, Jiaming
    Owyang, Chung
    Li, Jingnan
    CHINESE MEDICAL JOURNAL, 2022, 135 (19) : 2357 - 2359
  • [48] Probiotic Mixture VSL#3 Alleviates Dextran Sulfate Sodium-induced Colitis in Mice by Downregulating T Follicular Helper Cells
    Liu, Xiao-jing
    Yu, Ran
    Zou, Kai-fang
    CURRENT MEDICAL SCIENCE, 2019, 39 (03) : 371 - 378
  • [49] Regulation of TNF By the Probiotic Mixture, VSL#3, and Its Efficacy to Ameliorate TNF-Dependent Chronic Intestinal Inflammation in the TNF Dare Model of Crohn's Disease
    Mercado, Joseph R.
    Alford, Jonathan A.
    Meddings, Jonathan B.
    Pizarro, Theresa T.
    Cominelli, Fabio
    GASTROENTEROLOGY, 2009, 136 (05) : A771 - A771
  • [50] Probiotic mixture VSL#3 prevents ulcerative colitis-associated carcinogenesis in mice and cells by regulating the inflammatory and Wnt/β-catenin pathway
    Li Wenbin
    Wang Yanan
    Wang Chunsaier
    Wang Hongying
    Ma Yiming
    Yang Hong
    Zhao Xinhua
    Hu Xiaomin
    Kao John Y.
    Qian Jiaming
    Owyang Chung
    Li Jingnan
    中华医学杂志(英文版), 2022, 135 (19)